Showing 49–60 of 83 results

  • Letrozole (Letrozole) – 2.5 Mg

    Letrozole (Letrozole) – 2.5 Mg

    0 out of 5
    Price range: $85 through $225

    Letrozole 2.5 mg is a non‑steroidal aromatase inhibitor prescribed primarily for postmenopausal women with hormone receptor‑positive breast cancer. By inhibiting the aromatase enzyme, it significantly lowers estrogen production—helping to slow tumor growth and reduce the risk of recurrence. It’s commonly used as adjuvant therapy after surgery or as first-line treatment for advanced disease

    Select optionsDone This product has multiple variants. The options may be chosen on the product page
  • Lopimune (LopinavirRitonavir) – 200mg 50 Mg

    Lopimune (Lopinavir/Ritonavir) – 200mg / 50 Mg

    0 out of 5
    Price range: $180 through $540

    LopiMune delivers two key antiretroviral agents: lopinavir (200 mg) and ritonavir (50 mg) in one tablet. Ritonavir boosts lopinavir levels by inhibiting metabolism, optimizing plasma exposure, and improving viral suppression. This combination supports twice-daily dosing regimens under clinician guidance, offering reliable antiretroviral performance with minimized resistance risk.

    Select optionsDone This product has multiple variants. The options may be chosen on the product page
  • Lupride 1 Mg Injection (Leuprolide Acetate)

    Lupride 1 Mg Injection (Leuprolide Acetate)

    0 out of 5
    Price range: $35 through $99

    Lupride 1 mg Injection contains leuprolide acetate, a synthetic GnRH agonist used to suppress hormone production by desensitizing the pituitary gland over time. It is widely utilized in:

    • Prostate cancer (medical castration in advanced or metastatic disease)

    • Endometriosis and uterine fibroids (to reduce hormone-fueled growth and alleviate symptoms)

    • Central precocious puberty (to delay early onset puberty in children)

    Typically administered as a short course, Lupride disrupts natural hormone cycles, reducing estrogen or testosterone levels effectively under clinician monitoring.

    Select optionsDone This product has multiple variants. The options may be chosen on the product page
  • Lupride Depot 22.50 Mg

    Lupride Depot 22.50 Mg

    0 out of 5
    Price range: $390 through $925

    Lupride Depot 22.50 mg is a sustained-release depot injection containing leuprorelin acetate, a GnRH (gonadotropin-releasing hormone) agonist. Administered intramuscularly, it provides continuous hormone modulation over three months. It’s used under medical supervision to reduce sex hormone levels, helping manage conditions such as advanced prostate cancer, endometriosis, uterine fibroids, and central precocious puberty in children.

    Select optionsDone This product has multiple variants. The options may be chosen on the product page
  • MyHep All (SofosbuvirVelpatasvir) – 400mg100 Mg

    MyHep All (Sofosbuvir/Velpatasvir) – 400mg/100 Mg

    0 out of 5
    Price range: $300 through $870

    MyHep‑All delivers a potent combination of sofosbuvir (400 mg) and velpatasvir (100 mg), formulated as a single fixed-dose tablet for once-daily oral treatment of all genotypes of chronic hepatitis C virus (HCV) infection. This highly effective pan-genotypic regimen achieves high sustained virologic response (SVR) rates, reducing viral load, restoring liver function, and simplifying long-term adherence under medical supervision.

    Select optionsDone This product has multiple variants. The options may be chosen on the product page
  • P Carzine 50 Mg (Procarbazine)

    P Carzine 50 Mg (Procarbazine)

    0 out of 5
    Price range: $55 through $149

    P‑Carzine 50 mg contains procarbazine hydrochloride, an oral alkylating anticancer agent used as part of multi-drug chemotherapy regimens for Hodgkin’s lymphoma (e.g. MOPP, COPP) and certain high-grade gliomas. It functions by interfering with DNA synthesis in malignant cells, leading to tumor regression when administered under strict oncologic protocols.

    Select optionsDone This product has multiple variants. The options may be chosen on the product page
  • Pomalid 2 Mg (Pomalidomide)

    Pomalid 2 Mg (Pomalidomide)

    0 out of 5
    Price range: $248 through $710

    Pomalid 2 mg contains pomalidomide, an immunomodulatory agent used to treat multiple myeloma in patients who have previously received lenalidomide and a proteasome inhibitor. Pomalidomide works by modulating the immune system, inhibiting tumor cell growth, and disrupting the bone marrow microenvironment to achieve disease control.

    Select optionsDone This product has multiple variants. The options may be chosen on the product page
  • Pomalid 4 Mg (Pomalidomide)

    Pomalid 4 Mg (Pomalidomide)

    0 out of 5
    Price range: $333 through $985

    Pomalid 4 mg contains pomalidomide, a potent immunomodulatory agent indicated for the treatment of multiple myeloma in patients whose disease has relapsed or become refractory after previous therapy, including lenalidomide and a proteasome inhibitor. It exerts anti-myeloma effects by modulating the immune response, inhibiting malignant plasma cell growth, and altering the tumor microenvironment.

    Select optionsDone This product has multiple variants. The options may be chosen on the product page
  • Resihance (Regorafenib) – 40 Mg

    Resihance (Regorafenib) – 40 Mg

    0 out of 5
    Price range: $700 through $1,799

    Resihance 40 mg contains regorafenib, an oral multi‑kinase inhibitor targeting angiogenic, stromal, and oncogenic tyrosine kinases. It is approved as a later‑line treatment for:

    • Metastatic colorectal cancer after prior chemotherapy and targeted agents

    • Advanced gastrointestinal stromal tumors (GIST) refractory to imatinib and sunitinib

    • Hepatocellular carcinoma (HCC) in patients previously treated with sorafenib

    Regorafenib works by blocking kinase pathways essential for tumor growth and blood vessel formation, aiding in slowing disease progression.

    Select optionsDone This product has multiple variants. The options may be chosen on the product page
  • Rifagut 200 Mg (Rifaximin)

    Rifagut 200 Mg (Rifaximin)

    0 out of 5
    Price range: $42 through $135

    Refagut 200 mg features rifaximin, a locally acting antibiotic in the gut for treating traveler’s diarrhea caused by E. coli, irritable bowel syndrome with diarrhea (IBS‑D), and small intestinal bacterial overgrowth (SIBO). This lower-dose option offers targeted symptom relief and is ideal for short courses with limited systemic effects—supporting digestive balance under medical supervision.

    Select optionsDone This product has multiple variants. The options may be chosen on the product page
  • Rifagut 400 Mg

    Rifagut 400 Mg

    0 out of 5
    Price range: $20 through $56

    Rifagut 400 mg contains rifabutin, an antibiotic used in both combination tuberculosis treatment regimens and prophylaxis against Mycobacterium avium complex (MAC) in patients with HIV or immune suppression. It inhibits mycobacterial RNA synthesis and helps reduce bacterial load when used with standard anti-TB drugs. Rifagut is administered under medical guidance to ensure efficacy and safety.

    Select optionsDone This product has multiple variants. The options may be chosen on the product page
  • Rifagut 550 Mg (Rifaximin)

    Rifagut 550 Mg (Rifaximin)

    0 out of 5
    Price range: $90 through $260

    Refagut 550 mg contains rifaximin, a poorly absorbed antibiotic that acts locally within the gastrointestinal tract to combat E. coli infection in traveler’s diarrhea, reduce small intestinal bacterial overgrowth (SIBO), and ease symptoms of IBS‑D. This higher-strength formulation offers concentrated gut activity while minimizing systemic exposure, helping restore digestive balance under clinical supervision.

    Select optionsDone This product has multiple variants. The options may be chosen on the product page

End of content

End of content